MICHAEL COULTER: Open Payments
NPI 1194031880 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 39 payments from 12 companies in 2025. Trend: 2023 $887 · 2024 $713 · 2025 $838
Food & beverage: $838
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $211 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $210 |
| Vanda Pharmaceuticals Inc. | 5 | $93 |
| Theratechnologies Inc. | 2 | $72 |
| Corium, LLC | 3 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Almatica Pharma LLC | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
Products named: VRAYLAR, CAPLYTA, FANAPT, EGRIFTA, Azstarys, INVEGA SUSTENNA, REXULTI, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
